Effect of angiotensin II non-peptide AT1 antagonist losartan on phosphatidylethanolamine membranes

Biochimica et Biophysica Acta - Biomembranes

Volumn 1509, Issue 1-2, 2000, Pages 346-360

  Theodoropoulou, Efthimia ^a   Marsh, Derek ^a  

^a MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

Angiotensin II; Differential scanning calorimetry; Electron spin resonance spectroscopy; Losartan; Nuclear magnetic resonance spectroscopy; Phosphatidylethanolamine membranes

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIELAIDOYLPHOSPHATIDYLETHANOLAMINE; DIMYRISTOYLPHOSPHATIDYLETHANOLAMINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; ETHANOLAMINE DERIVATIVE; LOSARTAN; UNCLASSIFIED DRUG;

ARTICLE; DRUG EFFECT; MEMBRANE FLUIDITY; MEMBRANE STABILIZATION; MEMBRANE STRUCTURE; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY;

CALORIMETRY, DIFFERENTIAL SCANNING; ELECTRON SPIN RESONANCE SPECTROSCOPY; LIPID BILAYERS; LOSARTAN; MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHATIDYLETHANOLAMINES; RECEPTORS, ANGIOTENSIN; TEMPERATURE;

EID: 0034695071     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(00)00317-5     Document Type: Article

References (42)

1. Angiotensin/renin modulators
2. Angiotensin-converting enzyme inhibitors: A comparative review
3. New therapeutic prospects of renin-angiotensin system inhibition
4. Increased cough reflex associated with angiotensin converting enzyme inhibitor
5. Potentiation of inflammatory reactions in guinea-pig skin by an angiotensin converting enzyme inhibitor (MK 422)
6. Preclinical pharmacology of saralasin
7. Comparison between saralasin and converting enzyme inhibitor in hypertensive disease
8. Pressor responses to 1-Sar-8-Ala-angiotensin II (saralasin) in hypertensive subjects
9. The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist
10. Angiotensin II receptor antagonists: From discovery to antihypertensive drugs
11. 1 angiotensin receptor
12. Modelling G-protein-coupled receptors for drug design
13. Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes
14. 1 antagonist losartan with phospholipid membranes studied by combined use of differential scanning calorimetry and electron spin resonance spectroscopy
15. The application of biophysical methods to study drug: Membrane interactions
16. 31P-nuclear magnetic resonance spectroscopy with differential scanning calorimetry to study cannabinoid-membrane interactions
17. Thermal properties of adamantanol derivatives and their beta-cyclodextrin complexes in phosphatidylcholine bilayers
18. The use of high-resolution solid-state NMR spectroscopy and differential scanning calorimetry to study interactions of anaesthetic steroids with membrane
19. Studies on the thermotropic effects of cannabinoids on phosphatidylcholine bilayers using differential scanning calorimetry and small angle X-ray diffraction
20. Mode of insertion of the signal sequence of a bacterial precursor protein into phospholipid bilayers as revealed by cysteine-based site-directed spectroscopy
21. Interaction of α-lactalbumin with phosphatidylglycerol. Influence of protein binding on the lipid phase transition and lipid acyl chain mobility
22. Insertion of diphtheria toxin in lipid bilayers studied by spin label ESR
23. Spin-label studies of the structure and dynamics of lipids and proteins in membranes
24. Influence of annexin V on the structure and dynamics of phosphatidylcholine/phosphatidylserine bilayers: A fluorescence and NMR study
25. The interaction of abietic acid with phospholipid membranes
26. 31P NMR spectroscopy
27. NMR study of the interaction of retinoids with phospholipid bilayers
28. Spin-labeling and lipid-protein interactions in membranes
29. Electron spin resonance: Spin label probes
30. Chain configuration and flexibility gradient in phospholipid membranes. Comparison between spin-label electron spin resonance and deuteron nuclear magnetic resonance, and identification of new conformations
31. Phases and phase transitions of the hydrated phosphatidylethanolamines
32. 31P-NMR and differential scanning calorimetry
33. Gramicidin promotes formation of the hexagonal H(II) phase in aqueous dispersions of phosphatidylethanolamine and phosphatidylcholine
34. 31P NMR. Evidence that cholesterol may destabilize bilayer structure in membrane systems containing phosphatidylethanolamine
35. Network formation of lipid membranes: Triggering structural transitions by chain melting
36. Phospholipid bilayers. Physical principles and models
37. Solid solutions treatment of calorimetric purity data
38. Dynamic structure and phase behaviour of dimyristoylphosphatidylethanolamine bilayers studied by deuterium nuclear magnetic resonance
39. The modified stalk mechanism of lamellar/inverted phase transitions and its implications for membrane fusion
40. Effects of viral chemotherapeutic agents on membrane properties. Studies of cyclosporin A, benzyloxycarbonyl-D-Phe-L-Phe-Gly and amantadine